Lloyds Banking Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-60
| Closed | -$6K | – | 64 |
|
|
2017
Q2 | $6K | Sell |
60
-1,101
| -95% | -$110K | 0.06% | 58 |
|
|
2017
Q1 | $134K | Sell |
1,161
-142
| -11% | -$16.4K | 1.21% | 40 |
|
|
2016
Q4 | $156K | Sell |
1,303
-49
| -4% | -$5.87K | 1.36% | 37 |
|
|
2016
Q3 | $151K | Sell |
1,352
-51
| -4% | -$5.7K | 1.36% | 39 |
|
|
2016
Q2 | $173K | Hold |
1,403
| – | – | 1.42% | 36 |
|
|
2016
Q1 | $157K | Buy |
+1,403
| New | +$157K | 1.28% | 38 |
|
|
2014
Q2 | – | Sell |
-159,827
| Closed | -$31.7M | – | 534 |
|
|
2014
Q1 | $31.7M | Sell |
159,827
-11,460
| -7% | -$2.27M | 0.28% | 103 |
|
|
2013
Q4 | $32.7M | Sell |
171,287
-11,805
| -6% | -$2.25M | 0.3% | 89 |
|
|
2013
Q3 | $31M | Sell |
183,092
-18,409
| -9% | -$3.11M | 0.32% | 86 |
|
|
2013
Q2 | $30.6M | Buy |
+201,501
| New | +$30.6M | 0.32% | 81 |
|